Welcome Guest User | Login or Register

Investor Relations

Investor Relations

STERIS plc is a leading provider of infection prevention and procedural surgical products and services, focused primarily on the critical markets of healthcare, pharmaceutical and research and medical device companies. Our mission is to provide a healthier today and a safer tomorrow through knowledgeable people and innovative infection prevention, decontamination and health science technologies, products and services.

NYSE   |   STE (common stock)
$96.04 - 0.18
Stock chart for: STE.  Currently trading at $96.04 with a 52 week high of $97.47 and a 52 week low of $70.29.
04/20/18 4:02 p.m. ET
Data provided by Nasdaq. Minimum 15 minutes delayed.

Recent Press Releases

STERIS Announces Financial Results for Fiscal 2018 Third Quarter

Read More

STERIS to Announce Fiscal 2018 Third Quarter Financial Results on February 7, 2018

Read More

STERIS to Participate in the J.P. Morgan Healthcare Conference

Read More

Investor Events

Wednesday, February 7, 2018 
10:00 a.m. ET
Q3 2018 STERIS plc Earnings Conference Call
Monday, January 8, 2018 
4:00 p.m. PT
STERIS plc J.P. Morgan Breakout Q&A